Talis Biomedical Corp Retention Agreements
5 Contracts & Agreements
- Retention Agreement, dated August 19, 2024, by and between the Company and Rebecca Markovich, Interim Chief Financial Officer (Filed With SEC on August 19, 2024)
- Retention Agreement, dated August 19, 2024, by and between the Company and Robert Kelley, Chief Executive Officer (Filed With SEC on August 19, 2024)
- Retention Agreement, dated April 10, 2024, by and between the Company and Rebecca Markovich, Interim Chief Financial Officer (Filed With SEC on August 19, 2024)
- Retention Agreement, dated April 10, 2024, by and between the Company and Rebecca Markovich, Interim Chief Financial Officer (Filed With SEC on May 8, 2024)
- Retention Agreement, dated November 13, 2023, by and between the Company and Rebecca Markovich, Interim Chief Financial Officer (Filed With SEC on November 14, 2023)
